Status
Conditions
Treatments
About
Evaluate Survivorship for the Biomet® Comprehensive® Reverse Shoulder Mini Baseplate.
Full description
The primary objective of this prospective clinical data collection is to evaluate survivorship for the Biomet® Comprehensive® Reverse Shoulder Mini Baseplate. Secondary objectives include validation of implant sizing and hardware options as well as collection of mid-term clinical outcomes including adverse events, scapular notching, and Constant Score.
All shoulders on which data will be collected are legally marketed and none of the devices are investigational or experimental. FDA has cleared this device via Premarket Notification 510(k) K080642. This data collection effort will document the clinical outcomes of the Comprehensive® Reverse shoulders. The data gathered will be collated and used to provide feedback to designing engineers, support marketing efforts, and answer potential questions from reimbursement agencies.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients / cases to be included in this study shall utilize the following inclusion criteria:
Comprehensive Reverse Shoulder Mini Base Plate and Mini Stem in a reverse shoulder configuration.
The patient must be anatomically and structurally suited to receive the implants and a functional deltoid muscle is necessary.
Grossly deficient rotator cuff with severe arthropathy and/or
Exclusion criteria
Absolute contraindications include infection, sepsis, and osteomyelitis.
Relative contraindications include:
100 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal